Stock Events

Stock Events

Clinuvel Pharmaceuticals (UR9.STU) Q3 2026 Earnings

26AugConfirmed

Q1 2026

Q3 2026

0.12

0.18

0.24

0.3

Details

Expected EPS

0.29706374655936

Actual EPS

0.27884117888000004

Surprise EPS

-0.02

Surprise Percent

+6.13%

Description

Clinuvel Pharmaceuticals (UR9.STU) has reported earnings of 0.27884117888000004 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.